FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000590032> ?p ?o ?g. }

• W2000590032 endingPage "R158" @default.
• W2000590032 startingPage "R158" @default.
• W2000590032 abstract "Small increases in mean serum creatinine (SCr) were observed in studies of rheumatoid arthritis patients during tofacitinib treatment. These SCr changes were investigated and potential mechanisms explored. SCr values and renal adverse event data were pooled from five Phase 3 and two long-term extension (LTE) studies. Dose-response relationships and association with inflammation (C-reactive protein (CRP)) were explored using Phase 2 data and confirmed with Phase 3 data. In Phase 3, least squares mean SCr differences from placebo at Month 3 were 0.02 and 0.04 mg/dl for tofacitinib 5 and 10 mg twice daily (BID) (P <0.05), respectively. During Months 0 to 3, confirmed SCr ≥33% increases over baseline were reported in 17 (1.4%; 5 mg BID) and 23 (1.9%; 10 mg BID) patients. Generally, elevations plateaued and remained within normal limits throughout Phase 3 and LTE studies. Exposure-response modeling demonstrated small, reversible effects of tofacitinib on mean SCr, and significant (P <0.05) effects of CRP on model parameters. Phase 3 data confirmed that patients with higher baseline CRP or greater CRP decreases following tofacitinib treatment had the largest increases in SCr. Across Phase 3 and LTE studies, 22 tofacitinib-treated patients had clinical acute renal failure (ARF), predominantly in the setting of concurrent serious illness. Tofacitinib treatment was associated with small, reversible mean increases in SCr that plateaued early. The mechanism behind these SCr changes remains unknown, but may involve effects of tofacitinib on inflammation. ARF occurred infrequently, was associated with concurrent serious illness, and was unrelated to prior SCr increases." @default.
• W2000590032 created "2016-06-24" @default.
• W2000590032 creator A5008908941 @default.
• W2000590032 creator A5012671195 @default.
• W2000590032 creator A5015068573 @default.
• W2000590032 creator A5025366310 @default.
• W2000590032 creator A5031236528 @default.
• W2000590032 creator A5048376276 @default.
• W2000590032 creator A5053704561 @default.
• W2000590032 creator A5069255050 @default.
• W2000590032 creator A5072429797 @default.
• W2000590032 creator A5072936689 @default.
• W2000590032 date "2014-01-01" @default.
• W2000590032 modified "2023-10-18" @default.
• W2000590032 title "Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials" @default.
• W2000590032 cites W1932497847 @default.
• W2000590032 cites W1943293378 @default.
• W2000590032 cites W1963965880 @default.
• W2000590032 cites W1966833202 @default.
• W2000590032 cites W1987342012 @default.
• W2000590032 cites W1990105300 @default.
• W2000590032 cites W2006644254 @default.
• W2000590032 cites W2006813791 @default.
• W2000590032 cites W2009870147 @default.
• W2000590032 cites W2014330392 @default.
• W2000590032 cites W2035320881 @default.
• W2000590032 cites W2038992287 @default.
• W2000590032 cites W2046744512 @default.
• W2000590032 cites W2069302785 @default.
• W2000590032 cites W2072488504 @default.
• W2000590032 cites W2078380224 @default.
• W2000590032 cites W2086156659 @default.
• W2000590032 cites W2099334955 @default.
• W2000590032 cites W2101217991 @default.
• W2000590032 cites W2107195787 @default.
• W2000590032 cites W2112271094 @default.
• W2000590032 cites W2124097898 @default.
• W2000590032 cites W2129948300 @default.
• W2000590032 cites W2133462208 @default.
• W2000590032 cites W2139672588 @default.
• W2000590032 cites W2141348928 @default.
• W2000590032 cites W2149189075 @default.
• W2000590032 cites W2149447280 @default.
• W2000590032 cites W2153414586 @default.
• W2000590032 cites W2164858045 @default.
• W2000590032 cites W2403163284 @default.
• W2000590032 cites W3008096977 @default.
• W2000590032 cites W3025874617 @default.
• W2000590032 doi "https://doi.org/10.1186/ar4673" @default.
• W2000590032 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4220634" @default.
• W2000590032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25063045" @default.
• W2000590032 hasPublicationYear "2014" @default.
• W2000590032 type Work @default.
• W2000590032 sameAs 2000590032 @default.
• W2000590032 citedByCount "37" @default.
• W2000590032 countsByYear W20005900322014 @default.
• W2000590032 countsByYear W20005900322015 @default.
• W2000590032 countsByYear W20005900322016 @default.
• W2000590032 countsByYear W20005900322017 @default.
• W2000590032 countsByYear W20005900322018 @default.
• W2000590032 countsByYear W20005900322019 @default.
• W2000590032 countsByYear W20005900322020 @default.
• W2000590032 countsByYear W20005900322021 @default.
• W2000590032 countsByYear W20005900322022 @default.
• W2000590032 countsByYear W20005900322023 @default.
• W2000590032 crossrefType "journal-article" @default.
• W2000590032 hasAuthorship W2000590032A5008908941 @default.
• W2000590032 hasAuthorship W2000590032A5012671195 @default.
• W2000590032 hasAuthorship W2000590032A5015068573 @default.
• W2000590032 hasAuthorship W2000590032A5025366310 @default.
• W2000590032 hasAuthorship W2000590032A5031236528 @default.
• W2000590032 hasAuthorship W2000590032A5048376276 @default.
• W2000590032 hasAuthorship W2000590032A5053704561 @default.
• W2000590032 hasAuthorship W2000590032A5069255050 @default.
• W2000590032 hasAuthorship W2000590032A5072429797 @default.
• W2000590032 hasAuthorship W2000590032A5072936689 @default.
• W2000590032 hasBestOaLocation W20005900321 @default.
• W2000590032 hasConcept C126322002 @default.
• W2000590032 hasConcept C142724271 @default.
• W2000590032 hasConcept C197934379 @default.
• W2000590032 hasConcept C198451711 @default.
• W2000590032 hasConcept C204787440 @default.
• W2000590032 hasConcept C27081682 @default.
• W2000590032 hasConcept C2777575956 @default.
• W2000590032 hasConcept C2778886723 @default.
• W2000590032 hasConcept C2780306776 @default.
• W2000590032 hasConcept C71924100 @default.
• W2000590032 hasConcept C90924648 @default.
• W2000590032 hasConceptScore W2000590032C126322002 @default.
• W2000590032 hasConceptScore W2000590032C142724271 @default.
• W2000590032 hasConceptScore W2000590032C197934379 @default.
• W2000590032 hasConceptScore W2000590032C198451711 @default.
• W2000590032 hasConceptScore W2000590032C204787440 @default.
• W2000590032 hasConceptScore W2000590032C27081682 @default.
• W2000590032 hasConceptScore W2000590032C2777575956 @default.
• W2000590032 hasConceptScore W2000590032C2778886723 @default.
• W2000590032 hasConceptScore W2000590032C2780306776 @default.
• W2000590032 hasConceptScore W2000590032C71924100 @default.

• next